https://interactions.guidetherapeutiquevih.com/en/interaction-details?id=13506
No pharmaceutical opinion available for this interaction.
Phenobarbital can induce the metabolism (CYP 3A4) and decrease the plasma concentration of Cobicistat.
Risk of a possible development of resistance to antiretroviral class.
Possible decrease of the pharmacokinetic boosting effect.
Therefore, resulting in loss of therapeutic effect of associated IP.
Avoid this association or monitor for signs and symptoms of therapeutic failure.
–
–
Contraindicated. Use alternative.
Gabapentin, pregabalin, leviracetam.
–
Associated PI plasma level
Viral Load
CD4+
–
–